KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $75.2 million.

  • West Pharmaceutical Services' Other Non-Current Liabilities rose 2090.03% to $75.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $75.2 million, marking a year-over-year increase of 2090.03%. This contributed to the annual value of $75.2 million for FY2025, which is 2090.03% up from last year.
  • According to the latest figures from Q4 2025, West Pharmaceutical Services' Other Non-Current Liabilities is $75.2 million, which was up 2090.03% from $75.3 million recorded in Q3 2025.
  • West Pharmaceutical Services' 5-year Other Non-Current Liabilities high stood at $75.3 million for Q3 2025, and its period low was $27.8 million during Q3 2021.
  • Its 5-year average for Other Non-Current Liabilities is $52.2 million, with a median of $55.4 million in 2023.
  • As far as peak fluctuations go, West Pharmaceutical Services' Other Non-Current Liabilities plummeted by 4059.83% in 2021, and later surged by 6253.69% in 2023.
  • West Pharmaceutical Services' Other Non-Current Liabilities (Quarter) stood at $38.2 million in 2021, then skyrocketed by 35.08% to $51.6 million in 2022, then grew by 13.37% to $58.5 million in 2023, then increased by 6.32% to $62.2 million in 2024, then grew by 20.9% to $75.2 million in 2025.
  • Its last three reported values are $75.2 million in Q4 2025, $75.3 million for Q3 2025, and $70.4 million during Q2 2025.